We are live on ! Find out more
DWA

Dorsey Wright & Associates Portfolio holdings

AUM $807M
1-Year Est. Return 65.46%
This Fund
S&P 500
This Quarter Est. Return
+29.96%
1 Year Est. Return
+65.46%
3 Year Est. Return
+245.67%
5 Year Est. Return
10 Year Est. Return
AUM
$490M
AUM Growth
+$226M
Cap. Flow
+$149M
Cap. Flow %
30.35%
Top 10 Hldgs %
35.67%
Holding
392
New
133
Increased
17
Reduced
62
Closed
87

Top Sells

Rank Stock Value
1
CZZ
Cosan Limited
CZZ
+$3.5M
2
WNS
WNS Holdings
WNS
+$3.26M
3
TDG icon
TransDigm Group
TDG
+$2.98M
4
MSCI icon
MSCI
MSCI
+$2.66M
5
CRH icon
CRH
CRH
+$2.63M

Sector Composition

Rank Sector Weight
1 Healthcare 19.12%
2 Technology 14.43%
3 Materials 5.84%
4 Consumer Discretionary 5.38%
5 Consumer Staples 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEM icon
26
Newmont
NEM
$98.2B
$4.04M 0.82%
65,417
+39,990
+157% +$2.37M
NVO
27
Novo Nordisk
NVO
$216B
$3.89M 0.79%
118,548
-9,730
-8% -$310K
ALLE icon
28
Allegion
ALLE
$13B
$3.84M 0.78%
37,642
-3,132
-8% -$309K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$121B
$3.84M 0.78%
13,222
-586
-4% -$159K
ICLR icon
30
Icon
ICLR
$12.8B
$3.81M 0.78%
22,634
-1,802
-7% -$284K
VNET
31
VNET Group
VNET
$2.05B
$3.64M 0.74%
+147,814
New +$2.38M
CDNS icon
32
Cadence Design Systems
CDNS
$90B
$3.62M 0.74%
37,553
+9,995
+36% +$837K
XLK icon
33
State Street Technology Select Sector SPDR ETF
XLK
$115B
$3.55M 0.73%
67,998
-2,896
-4% -$136K
WST icon
34
West Pharmaceutical
WST
$23.1B
$3.53M 0.72%
15,601
+3,046
+24% +$598K
CHTR icon
35
Charter Communications
CHTR
$14.7B
$3.53M 0.72%
6,925
-615
-8% -$312K
EDU icon
36
New Oriental
EDU
$7.84B
$3.51M 0.72%
26,887
-2,420
-8% -$295K
LOGI icon
37
Logitech
LOGI
$15.2B
$3.34M 0.68%
+51,460
New +$2.74M
RDY icon
38
Dr. Reddy's Laboratories
RDY
$9.82B
$3.33M 0.68%
316,355
-27,285
-8% -$278K
SBSW icon
39
Sibanye-Stillwater
SBSW
$5.92B
$3.3M 0.67%
381,444
-35,067
-8% -$267K
DECK icon
40
Deckers Outdoor
DECK
$13.3B
$3.17M 0.65%
96,876
+72
+0.1% +$1.98K
MASI
41
DELISTED
Masimo
MASI
$3.11M 0.63%
13,629
-1,373
-9% -$301K
SAP icon
42
SAP
SAP
$187B
$2.94M 0.6%
20,988
-1,749
-8% -$216K
SNN icon
43
Smith & Nephew
SNN
$12.9B
$2.94M 0.6%
75,420
-6,070
-7% -$241K
NVS icon
44
Novartis
NVS
$295B
$2.88M 0.59%
32,819
-2,645
-7% -$228K
VIPS icon
45
Vipshop
VIPS
$6.84B
$2.87M 0.59%
+144,735
New +$2.49M
GMAB icon
46
Genmab
GMAB
$17.7B
$2.85M 0.58%
+85,335
New +$2.33M
EW icon
47
Edwards Lifesciences
EW
$47.6B
$2.85M 0.58%
+41,243
New +$2.93M
AJG icon
48
Arthur J. Gallagher & Co
AJG
$63.7B
$2.83M 0.58%
29,031
+3,587
+14% +$318K
DBP icon
49
Invesco DB Precious Metals Fund
DBP
$237M
$2.76M 0.56%
57,634
-2,533
-4% -$115K
NGG icon
50
National Grid
NGG
$82.7B
$2.73M 0.56%
51,198
-4,026
-7% -$204K

Similar funds

Dorsey Wright & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Dorsey Wright & Associates held 392 positions worth $490M, up 86% from $264M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Dorsey Wright & Associates deployed $149M of net new capital in Q2 2020, opening 133 new positions and adding to 17 existing holdings. Its largest new stake was Invesco QQQ Trust: 247,110 shares worth $61.9M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was MSCI, an estimated $2.66M trimmed.

  • Dorsey Wright & Associates's largest Q2 2020 buy was Invesco QQQ Trust: 247,110 shares worth $61.9M.
  • Dorsey Wright & Associates added most to iShares MSCI USA Momentum Factor ETF in Q2 2020, an estimated $21M increase.
  • Dorsey Wright & Associates's biggest Q2 2020 reduction was MSCI, cutting an estimated $2.66M.
  • Dorsey Wright & Associates fully exited Cosan Limited in Q2 2020, selling an estimated $3.5M.
  • Dorsey Wright & Associates's ten largest holdings make up 36% of its $490M portfolio in Q2 2020.
  • Dorsey Wright & Associates opened 133 new positions and closed 87 in Q2 2020.
  • Dorsey Wright & Associates's portfolio value rose 86% quarter-over-quarter to $490M.

Based on Dorsey Wright & Associates's 13F filing for Q2 2020, filed 23 Jul 2020.